The IM8 brand is demonstrating accelerating growth with strong unit economics and a raised guidance, which should drive positive momentum. However, the company remains loss-making and the warrants/digital asset valuation workstreams introduce some near-term uncertainty. Watch for the full Q1 earnings release and the Q2 trajectory to confirm the sustainability of the 33% sequential growth rate.
Price Chart
Executive Summary
Prenetics reported preliminary Q1 2026 revenue of $36.0M (up 334.5% YoY from $8.3M), driven by IM8 revenue of $33.8M (up ~6x YoY from $5.7M). The company raised full-year 2026 IM8 revenue guidance to $190M-$210M (from $180M-$200M) and guided Q2 2026 total revenue of $46M-$48M. Despite strong top-line growth, the company remains unprofitable with an adjusted EBITDA loss of $5.6M (wider than $4.5M loss in Q1 2025). The company also completed a $41.3M digital asset divestiture and executed ~$19M of a $40M buyback program, ending with an estimated $147M in total liquidity.
Key Facts
- Q1 2026 total revenue $36.0M, up 334.5% YoY from $8.3M
- IM8 revenue $33.8M, up ~6x YoY from $5.7M and up 23.1% sequentially from Q4 2025's $27.4M
- Full-year 2026 IM8 revenue guidance raised to $190M-$210M (from $180M-$200M)
- Q2 2026 revenue guidance $46M-$48M, implying ~30% sequential growth
- IM8 gross margin improved to 64% in Q1 2026 from 60% in Q4 2025
- Adjusted EBITDA loss of $5.6M in Q1 2026, wider than $4.5M loss in Q1 2025
- Cash and cash equivalents $56.0M as of March 31, 2026, with no debt
- Post-quarter digital asset divestiture generated $41.3M in cash proceeds
- Estimated total liquidity of ~$147M as of May 13, 2026 (cash + financial assets + escrow)
- Executed ~$19M of $40M share buyback program through May 13, 2026
- IM8 shipped to 43 countries with over 60% of revenue outside the US
- New product launches planned for Q4 2026 in hydration, creatine, and kids gummies
Financial Impact
Q1 revenue of $36.0M vs $8.3M YoY (+334.5%); IM8 revenue $33.8M vs $5.7M YoY; raised FY2026 IM8 guidance to $190M-$210M; adjusted EBITDA loss widened to $5.6M from $4.5M; cash position strengthened to ~$147M total liquidity
Risk Factors
- Preliminary results subject to completion of quarter-end closing procedures and valuation workstreams
- Adjusted EBITDA loss widened to $5.6M from $4.5M YoY, indicating ongoing cash burn
- Customer orders declined 4% QoQ due to subscription plan transition, which could signal demand lumpiness
- Dependence on IM8 for nearly 94% of total revenue creates concentration risk
- Forward guidance assumes continued acceleration, which may not materialize if consumer demand softens
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-034810 |
| Document: a6-kx2026q1prelim.htm | 0001628280-26-034810 |
| Document: 0001628280-26-034810-index-headers.html | 0001628280-26-034810 |
| Document: 0001628280-26-034810-index.html | 0001628280-26-034810 |
| Document: 0001628280-26-034810.txt | 0001628280-26-034810 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 10, 2026 19w ago | 6-K | $0.0195 $0.0157 | ▼ −19.49% | ▼ −23.38% | — |
Jun 4, 2026 20w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▲ +1.37% | — |
May 20, 2026 22w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▼ −1.00% | — |
May 14, 2026 23w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▲ +0.86% | — |
May 14, 2026 23w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▲ +0.86% | — |
May 4, 2026 25w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▼ −5.65% | — |
Apr 2, 2026 29w ago | 6-K | $0.0195 $0.0195 | · 0.00% | ▼ −9.88% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers